# K180030: TYRX Absorbable Antibacterial Envelope (medium), TYRX Absorbable Antibacterial Envelope (large)

- Pathway: 510(k) (Traditional)
- Applicant: Medtronic, Inc.
- Decided: Apr 24, 2018 after 111 days
- Product code: FTL (Mesh, Surgical, Polymeric)
- Device class: 2
- Regulation: 21 CFR 878.3300
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K931386 (1993). 20 ancestors in all.
3 later devices descend from it; 1 cites it directly.
0 of 24 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K130943: Aigis RX R PM/ Aigis RX R Icd, Tyrx, Inc. (2013) Summary page 4.

## Most influential descendants
- K192389: TYRX Absorbable Antibacterial Envelope (medium), TYRX Absorbable Antibacterial Envelope (large) (2020), 2 descendants of its own
- K233991: CanGaroo RM Antibacterial Envelope (2024), 1 descendant of its own
- K262406: EluPro Antibiotic-Eluting BioEnvelope (2026), 0 descendants of its own

## Indications for use
The absorbable antibacterial envelope is intended to hold a pacemaker pulse generator or defibrillator securely in order to provide a stable environment when implanted in the body. The absorbable antibacterial envelope contains the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection in an in vivo model of bacterial challenge following surgical implantation of the generator or defibrillator. This device is only intended to be used in conjunction with pacemakers and implantable defibrillators.

Source page: https://510kreport.com/device/K180030
Methodology: https://510kreport.com/methodology